Colitis: Clinical Trials

15 trials for Colitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 recruiting. 15 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 415Recruiting 15

Follow Colitis: new trials by email Literature Review of Colitis trials Research Report on Colitis

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
Breast Milk Sample Collection, Guselkumab - Psoriasis, Colitis, Ulcerative
Phase 4RecruitingJanssen Research & Development, LLC102026-08-072026-10-05
Stopping PPI Therapy in Inactive IBD
Continue PPI Therapy, Withdraw PPI Therapy - Ulcerative Colitis (UC), Crohn's Disease
Phase 4RecruitingUniversity of Nottingham802026-07-012026-07-08
Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed Moderate-to-severe Ulcerative Colitis
Mirikizumab, Azathioprine (AZA) - Ulcerative Colitis (UC)
Phase 4RecruitingUniversity Hospital Schleswig-Holstein3002025-12-052025-12-16
Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety
Interleukin 23 - Crohn's Disease and Ulcerative Colitis
Phase 4RecruitingSixth Affiliated Hospital, Sun Yat-sen University2002025-12-012026-04-24
De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis
Ustekinumab 90 mg SC q8w, Ustekinumab 90 mg SC q12w - Crohn Disease (CD), Ulcerative Colitis (UC)
Phase 4RecruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre1152025-10-082025-12-26
The Efficacy of Lactobacillous Probiotic and Trace Elements in the Management of Ulcerative Colitis Patients the Patients Will be Recruited From Outpatient Clinic of Inflammatory Bowel Disease (IBD) of the National Hepatology and Tropical Medicine Research Institute NHTMRI, Cairo, Egypt
Lactobacillus acidophilus will be assigned for arm 1, trace elements, Control Arm - standard of care - Ulcerative Colitis (UC)
Phase 4RecruitingNational Hepatology & Tropical Medicine Research Institute1322025-07-022026-09-16
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Vedolizumab IV, Vedolizumab SC - Ulcerative Colitis, Crohn's Disease
Phase 4RecruitingTakeda2002025-03-272026-10-28
The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis
VSL#3, Placebo, Vedolizumab - Ulcerative Colitis
Phase 4RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine1002024-09-212024-09-24
Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease.
KleanLyte, Bi-PegLyte - Crohn Disease, Ulcerative Colitis
Phase 4RecruitingUniversity of Manitoba4182024-07-042025-01-08
Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
Infliximab - Inflammatory Bowel Diseases, Crohn Disease
Phase 4RecruitingBelgian Inflammatory Bowel Disease Research and Development (BIRD) VZW2752024-04-092024-07-26
Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
Low Dose Budesonide, High Dose Budesonide, Placebo - Ulcerative Colitis
Phase 4RecruitingBausch Health Americas, Inc.702023-09-292025-09-16
Top Down Versus Step up in Pediatric Ulcerative Colitis
Infliximab, Corticosteroids - Ulcerative Colitis, Infliximab
Phase 4RecruitingChildren's Hospital of Fudan University402021-11-012024-02-28
Impact of Anti-TNF, Vedolizumab and Tofacitinib on Aortic Stiffness, Carotid Intima-media Thickness and Cardiovascular Risk of Patients With Ulcerative Colitis
Aortic pulse wave velocity, carotid intima media thickness (CIMT) - Ulcerative Colitis
Phase 4RecruitingCentre Hospitalier Universitaire, Amiens1002021-02-022025-05-29
Study of the Effect of Vedolizumab on Intestinal Microecological Changes and Its Efficacy in the Treatment of Ulcerative Colitis
Vedolizumab - Ulcerative Colitis
Phase 4RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine302021-01-012025-07-25
A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab
Adalimumab, Calprotectin, e-Monitoring - Ulcerative Colitis
Phase 4RecruitingGroupe d'Etude Therapeutique des Affections Inflammatoires Digestives2382020-01-142023-05-31

Narrower conditions

Colitis, Ulcerative (15)  ·  Crohn Disease (7)  ·  Arthritis, Psoriatic (1)  ·  Inflammatory Bowel Diseases (1)  ·  Psoriasis (1)

Broader conditions

Colonic Diseases (15)  ·  Digestive System Diseases (15)  ·  Gastroenteritis (15)  ·  Gastrointestinal Diseases (15)  ·  Intestinal Diseases (15)  ·  Inflammatory Bowel Diseases (14)  ·  Arthritis (1)  ·  Bone Diseases (1)  ·  Joint Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Papulosquamous (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Spinal Diseases (1)

Interventions

vedolizumab (3)  ·  Infliximab (2)  ·  Adalimumab (1)  ·  Adrenal Cortex Hormones (1)  ·  Azathioprine (1)  ·  Budesonide (1)  ·  Carotid Intima-Media Thickness (1)  ·  Injections (1)  ·  Interleukin-23 (1)  ·  Mesalamine (1)  ·  Trace Elements (1)  ·  Ustekinumab (1)  ·  guselkumab (1)  ·  mirikizumab (1)

Sponsors

Second Affiliated Hospital, Zhejiang University, School of Medicine (2)  ·  Bausch Health Americas, Inc. (1)  ·  Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Children's Hospital of Fudan University (1)  ·  Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives (1)  ·  Janssen Research & Development, LLC (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  National Hepatology & Tropical Medicine Research Institute (1)  ·  Sixth Affiliated Hospital, Sun Yat-sen University (1)  ·  Takeda (1)  ·  University Hospital Schleswig-Holstein (1)  ·  University of Manitoba (1)  ·  University of Nottingham (1)

Countries

China (4)  ·  United States (3)  ·  Canada (2)  ·  France (2)  ·  Belgium (1)  ·  Egypt (1)  ·  Germany (1)  ·  United Kingdom (1)

Top investigators

Annick Moens, MD, PhD (1)  ·  Tom Holvoet, MD, PhD (1)  ·  Varsha Bhatt (1)  ·  Yan Chen (1)  ·  Ying Huang (1)

Results publications

PMID 40243391

NIH funding

2025 (1)